id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
dpc-3703	Dessinioti, Clio; Stratigos, Alexander 	Immunotherapy and Its Timing in Advanced Basal Cell Carcinoma Treatment	2023	12	.pdf	application/pdf	9112	858	64	For patients with advanced basal cell carcinoma (BCC), including locally advanced or metastatic BCC not amenable to curative surgery or radiotherapy, hedgehog pathway inhibitors (HHI) vismodegib and sonidegib are approved as first-line systemic treatment. Vismodegib in patients with advanced basal cell carcinoma: Primary anal- ysis of STEVIE, an international, open-label trial.	cache/dpc-3703.pdf	txt/dpc-3703.txt